THERAPEUTIC AREA
saveDermatology
Diseases of the skin.
also known as: derm, skin
🐶 often sniffed alongside
top 8- tagRecall56 co-mentions · 33 sources
- tagAdCom44 co-mentions · 30 sources
- drugbenzoyl peroxide27 co-mentions · 7 sources
- tag510(k) Clearance26 co-mentions · 23 sources
- tagPMA Approval18 co-mentions · 7 sources
- druginsulin10 co-mentions · 2 sources
- tagOncology9 co-mentions · 4 sources
- tagInfectious Disease7 co-mentions · 4 sources
drugs
300
catalysts
31
news
395
companies
242
Top drugs
view all →Marketed
CLEOCIN
$PFE · 127 catalysts
Marketedclindamycin hydrochloride
Bacterial Pneumonia
90 catalysts
MarketedNALBUPHINE HYDROCHLORIDE
Pain
84 catalysts
Marketedadalimumab
Intermediate Uveitis
$ABBV · 61 catalysts
MarketedDOXYCYCLINE HYCLATE
$AMRX · 49 catalysts
Marketedmethylprednisolone sodium succinate
Drug Hypersensitivity Reactions
48 catalysts
MarketedEfudex
Basal Cell Carcinoma (Basal Cell Epithelioma)
42 catalysts
MarketedMETHYLPREDNISOLONE ACETATE
Giant Cell Arteritis (Temporal Arteritis/Cranial Arteriti…
41 catalysts
🐶 Top companies
view all →Recent catalysts
view all →Apr 30, 2026
phase 2 completion
Chinese Academy of Medical Sciences Plastic Surgery Hospital — recombinant type III humanized collagen (Phase II Trial Completion)
recombinant type III humanized collagen
→
Apr 30, 2026
phase 2 completion
Jetema Co Ltd — JTM-102 (Phase II Trial Completion)
JTM-102
→
Apr 30, 2026
phase 2 completion
Nigde Omer Halisdemir University — ozonated oil (Phase II Trial Completion)
ozonated oil
→
Apr 30, 2026
phase 2 completion
Vaidya Yagya Dutt Sharma Ayurvedic P. G. Mahavidhyalaya — ayurvedic medicine (Phase II Trial Completion)
ayurvedic medicine
→
Apr 30, 2026
phase 1 2 completion
Centre International de Développement Pharmaceutique — afamelanotide (Phase I/II Trial Completion)
afamelanotide
→
Apr 30, 2026
phase 1 2 completion
University Hospital Geneva — verteporfin (Phase I/II Trial Completion)
verteporfin
→
Apr 30, 2026
phase 1 initiation
$MRK144.30+0.34%
Merck & Co Inc — MK-6050 (Phase I Trial Initiation)
MK-6050
→
Apr 30, 2026
phase 1 initiation
Jiangsu Vcare PharmaTech Co Ltd — VC-005 (Phase I Trial Initiation)
VC-005
→
Apr 30, 2026
phase 0 trial completion
Foundation for the Promotion of Health and Biomedical Research of Valencia — Aquacel Ag + (Phase 0 Trial Completion)
Aquacel Ag +
→
Apr 30, 2026
phase 0 trial completion
Shanghai Jiao Tong University — insulin (Phase 0 Trial Completion)
insulin
→
Recent news
view all →- Lilly signals move into aesthetics, looking to add products for body, skin and hairendpoints · 1d ago
- Foghorn cuts 40% of workforcebiospace · 1d ago
- Sanofi, Regeneron broaden alliance to find their next Dupixentbiopharma dive · 2d ago
- Merck’s antibody impresses with ‘highly competitive’ data in chronic skin diseasebiospace · 2d ago
- Pfizer’s eczema drug clears skin in mid-stage trialbiopharma dive · 2d ago
- Merck’s anti-TL1A antibody secures a win in ph. 2 hidradenitis suppurativa trialfiercebiotech · 3d ago
- #EADV26: Merck shows off mid-stage win for Prometheus drug in skin conditionendpoints · 3d ago
- Amgen reveals 6-point drop in lupus severity behind phase 2 win for Horizon antibodyfiercebiotech · 3d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that